How to buy Invitae Corporation stock | $52.58

Invitae Corporation is a diagnostics & research business based in the US. Invitae Corporation shares (NVTA) are listed on the NYSE and all prices are listed in US Dollars. Invitae Corporation employs 1,900 staff and has a trailing 12-month revenue of around USD$245.5 million.

How to buy shares in Invitae Corporation

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Invitae Corporation. Find the stock by name or ticker symbol: NVTA. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Invitae Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$52.58, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Invitae Corporation, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Invitae Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Invitae Corporation share price

Use our graph to track the performance of NVTA stocks over time.

Invitae Corporation shares at a glance

• Key figures

Information last updated 2020-12-02.

Latest market close	USD$52.58
52-week range	USD$7.415 - USD$55.38
50-day moving average	USD$46.2311
200-day moving average	USD$34.7761
Wall St. target price	USD$46.31
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.874

Buy Invitae Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Invitae Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Invitae Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Invitae Corporation price performance over time

Historical closes compared with the close of $52.58 from 2020-12-09

1 week (2021-01-08)	2.84%
1 month (2020-12-17)	11.54%
3 months (2020-10-16)	11.80%
6 months (2020-07-17)	60.94%

1 year (2020-01-17)	167.86%
2 years (2019-01-17)	267.18%
3 years (2018-01-17)	676.66%
5 years (2016-01-15)	636.41%

Invitae Corporation financials

Revenue TTM	USD$245.5 million
Gross profit TTM	USD$98.7 million
Return on assets TTM	-25.68%
Return on equity TTM	-108.42%
Profit margin	-181.19%
Book value	$3.126
Market capitalisation	USD$8.7 billion

TTM: trailing 12 months

Shorting Invitae Corporation shares

There are currently 26.1 million Invitae Corporation shares held short by investors – that's known as Invitae Corporation's "short interest". This figure is 15.3% up from 22.6 million last month.

There are a few different ways that this level of interest in shorting Invitae Corporation shares can be evaluated.

Invitae Corporation's "short interest ratio" (SIR)

Invitae Corporation's "short interest ratio" (SIR) is the quantity of Invitae Corporation shares currently shorted divided by the average quantity of Invitae Corporation shares traded daily (recently around 2.7 million). Invitae Corporation's SIR currently stands at 9.67. In other words for every 100,000 Invitae Corporation shares traded daily on the market, roughly 9670 shares are currently held short.

However Invitae Corporation's short interest can also be evaluated against the total number of Invitae Corporation shares, or, against the total number of tradable Invitae Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Invitae Corporation's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 Invitae Corporation shares in existence, roughly 150 shares are currently held short) or 0.1481% of the tradable shares (for every 100,000 tradable Invitae Corporation shares, roughly 148 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Invitae Corporation.

Find out more about how you can short Invitae Corporation stock.

Invitae Corporation share dividends

We're not expecting Invitae Corporation to pay a dividend over the next 12 months.

Invitae Corporation share price volatility

Over the last 12 months, Invitae Corporation's shares have ranged in value from as little as $7.415 up to $55.38. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Invitae Corporation's is 2.1477. This would suggest that Invitae Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Invitae Corporation overview

Invitae Corporation, a medical genetics company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. It offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, metabolic conditions, and rare diseases; prenatal and perinatal genetic tests; and non-invasive prenatal screening products. The company also provides preimplantation and carrier screening for inherited disorders; products for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders; a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, a platform for collecting and managing genetic family histories to deliver personalized genetic risk information. It serves patients, healthcare providers, and biopharma and advocacy partners. Invitae Corporation has a collaboration with Gene Therapies Ltd. for the detection of lysosomal storage disorders in children; and a research collaboration with Pacific Biosciences of California, Inc. for the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.

Frequently asked questions

• What percentage of Invitae Corporation is owned by insiders or institutions?

  Currently 1.283% of Invitae Corporation shares are held by insiders and 73.499% by institutions.

• How many people work for Invitae Corporation?

  Latest data suggests 1,900 work at Invitae Corporation.

• When does the fiscal year end for Invitae Corporation?

  Invitae Corporation's fiscal year ends in December.

• Where is Invitae Corporation based?

  Invitae Corporation's address is: 1400 16th Street, San Francisco, CA, United States, 94103

• What is Invitae Corporation's ISIN number?

  Invitae Corporation's international securities identification number is: US46185L1035

• What is Invitae Corporation's CUSIP number?

  Invitae Corporation's Committee on Uniform Securities Identification Procedures number is: 46185L103